Table 2 Treatment and outcome of BM patients
From: Analysis of prognostic factors in patients with brain metastases affecting survival
Variables | Options | Number (%) |
|---|---|---|
Radiation therapy | WBRT | 104 (89.6) |
WBRT + Boost | 03 (2.6) | |
SRS | 07 (6.0) | |
SRT | 02 (1.8) | |
Dose of radiation therapy | 18–24Gy/1 fr | 07 (6.0) |
27–33Gy/3fr | 02 (1.8) | |
8–40Gy/1–15 fr | 107 (92.2) | |
Present status | Alive | 09 (7.8) |
Death | 47 (40.5) | |
Lost to follow-up | 60 (51.7) | |
OS (after BM) | Less than 6 months | 22 (18.9) |
6–12 months | 18 (15.5) | |
1–2 years | 07 (6.0) | |
More than 2 years | 09 (7.8) |